Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 1
1967 3
1968 3
1969 7
1970 9
1971 5
1972 7
1973 2
1974 12
1975 3
1976 5
1977 7
1978 13
1979 3
1980 5
1981 6
1982 4
1983 5
1984 22
1985 14
1986 4
1987 22
1988 25
1989 35
1990 36
1991 41
1992 62
1993 50
1994 75
1995 65
1996 51
1997 57
1998 44
1999 57
2000 66
2001 70
2002 40
2003 71
2004 70
2005 67
2006 59
2007 59
2008 60
2009 78
2010 55
2011 85
2012 85
2013 98
2014 77
2015 105
2016 132
2017 115
2018 118
2019 122
2020 132
2021 109
2022 104
2023 150
2024 24

Text availability

Article attribute

Article type

Publication date

Search Results

2,638 results

Results by year

Filters applied: . Clear all
Page 1
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. Louis DN, et al. Acta Neuropathol. 2016 Jun;131(6):803-20. doi: 10.1007/s00401-016-1545-1. Epub 2016 May 9. Acta Neuropathol. 2016. PMID: 27157931 Review.
Other notable changes include the addition of brain invasion as a criterion for atypical meningioma and the introduction of a soft tissue-type grading system for the now combined entity of solitary fibrous tumor / hemangiopericytoma-a departure from the manner by which oth …
Other notable changes include the addition of brain invasion as a criterion for atypical meningioma and the introduction of a soft ti …
An overview of meningiomas.
Buerki RA, Horbinski CM, Kruser T, Horowitz PM, James CD, Lukas RV. Buerki RA, et al. Future Oncol. 2018 Sep;14(21):2161-2177. doi: 10.2217/fon-2018-0006. Epub 2018 Aug 7. Future Oncol. 2018. PMID: 30084265 Free PMC article. Review.
Meningiomas are the most common primary intracranial tumor. Important advances are occurring in meningioma research. These are expected to accelerate, potentially leading to impactful changes on the management of meningiomas in the near and medium term. ...
Meningiomas are the most common primary intracranial tumor. Important advances are occurring in meningioma research. These are expect …
Brain Tumors.
McFaline-Figueroa JR, Lee EQ. McFaline-Figueroa JR, et al. Am J Med. 2018 Aug;131(8):874-882. doi: 10.1016/j.amjmed.2017.12.039. Epub 2018 Jan 31. Am J Med. 2018. PMID: 29371158 Review.
Epidemiology and etiology of meningioma.
Wiemels J, Wrensch M, Claus EB. Wiemels J, et al. J Neurooncol. 2010 Sep;99(3):307-14. doi: 10.1007/s11060-010-0386-3. Epub 2010 Sep 7. J Neurooncol. 2010. PMID: 20821343 Free PMC article. Review.
People with certain mutations in the neurofibromatosis gene (NF2) have a very substantial increased risk for meningioma. High dose ionizing radiation exposure is an established risk factor for meningioma, and lower doses may also increase risk, but which types and d …
People with certain mutations in the neurofibromatosis gene (NF2) have a very substantial increased risk for meningioma. High dose io …
Current treatment options for meningioma.
Apra C, Peyre M, Kalamarides M. Apra C, et al. Expert Rev Neurother. 2018 Mar;18(3):241-249. doi: 10.1080/14737175.2018.1429920. Epub 2018 Jan 22. Expert Rev Neurother. 2018. PMID: 29338455 Free article. Review.
With an annual incidence of 5/100,000, meningioma is the most frequent primary tumor of the central nervous system. ...
With an annual incidence of 5/100,000, meningioma is the most frequent primary tumor of the central nervous system. ...
Molecular alterations in meningioma: prognostic and therapeutic perspectives.
Birzu C, Peyre M, Sahm F. Birzu C, et al. Curr Opin Oncol. 2020 Nov;32(6):613-622. doi: 10.1097/CCO.0000000000000687. Curr Opin Oncol. 2020. PMID: 32890025 Review.
PURPOSE OF REVIEW: To discuss recent advances in the meningioma biology and their clinical implications. RECENT FINDINGS: Meningioma is the most common primary intracranial tumor. ...Moreover, the study of distinct meningioma populations such as radiation-ind …
PURPOSE OF REVIEW: To discuss recent advances in the meningioma biology and their clinical implications. RECENT FINDINGS: Meningio
Meningioma.
Marosi C, Hassler M, Roessler K, Reni M, Sant M, Mazza E, Vecht C. Marosi C, et al. Crit Rev Oncol Hematol. 2008 Aug;67(2):153-71. doi: 10.1016/j.critrevonc.2008.01.010. Epub 2008 Mar 14. Crit Rev Oncol Hematol. 2008. PMID: 18342535 Review.
Radiotherapy is currently used in the clinical practice in atypical, malignant or recurrent meningioma at a total dose of 45-60Gy. However, the role of adjuvant irradiation is still controversial and has to be compared in a randomised prospective setting with a policy of w …
Radiotherapy is currently used in the clinical practice in atypical, malignant or recurrent meningioma at a total dose of 45-60Gy. Ho …
EANO guidelines for the diagnosis and treatment of meningiomas.
Goldbrunner R, Minniti G, Preusser M, Jenkinson MD, Sallabanda K, Houdart E, von Deimling A, Stavrinou P, Lefranc F, Lund-Johansen M, Moyal EC, Brandsma D, Henriksson R, Soffietti R, Weller M. Goldbrunner R, et al. Lancet Oncol. 2016 Sep;17(9):e383-91. doi: 10.1016/S1470-2045(16)30321-7. Epub 2016 Aug 30. Lancet Oncol. 2016. PMID: 27599143 Free article. Review.
Although meningiomas are the most common intracranial tumours, the level of evidence to provide recommendations for the diagnosis and treatment of meningiomas is low compared with other tumours such as high-grade gliomas. The meningioma task force of the European Associati …
Although meningiomas are the most common intracranial tumours, the level of evidence to provide recommendations for the diagnosis and treatm …
Emerging systemic treatment options in meningioma.
Mair MJ, Berghoff AS, Brastianos PK, Preusser M. Mair MJ, et al. J Neurooncol. 2023 Jan;161(2):245-258. doi: 10.1007/s11060-022-04148-8. Epub 2022 Oct 1. J Neurooncol. 2023. PMID: 36181606 Free PMC article. Review.
Conversely, the evidence for pharmacotherapy in meningioma is scarce. METHODS: The available literature of systemic treatment in meningioma was screened using PubMed, and ongoing clinical trials were explored using ClinicalTrials.gov. ...Moreover, results of recent …
Conversely, the evidence for pharmacotherapy in meningioma is scarce. METHODS: The available literature of systemic treatment in m
2,638 results